PharmaShots | Incisive News in 3 Shots

Subscribe Now

Xplore Clinical Trial

STADA and Xbrane's Xlucane (biosimilar- ranibizumab) Meet its Primary Endpoint in P-III Xplore Study

STADA and Xbrane's Xlucane (biosimilar- ranibizumab) Meet its Primary Endpoint in P-III Xplore Study

July 1, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us